ContraFect Announces Publication on Exebacase and CF-296 Demonstrating Potent In Vivo Antimicrobial Activity in Implant-Associated MRSA Osteomyelitis
YONKERS, N.Y., Aug. 15, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
Londian Wason Signs Cooperation Agreement in Kazakhstan to Jointly Build a High-Performance Electrolytic Copper Foil Production Base with NAIKAN Ltd.
From Robot Companions to Robot Cafe: Star Plus Legend Reimagines Consumer Experiences Through IP+Physical AI
Hong Kong International Wine & Spirits Fair attracts over 8,200 buyers with enthusiastic participation on Public Day
Six dirhams a gate. The real 2026 cost of a Dubai commute and three ways out
Spiking Joins IBM Z Day 2026 Asia Pacific Special Edition Track as a Friend of the IBM Z Community